Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Siloam International Hospitals Tbk. (SILO)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Siloam International Hospitals Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Siloam International Hospitals Tbk. diperdagangkan di Rp2.010 (kapitalisasi pasar 26,53 T, volume 24 jam 613,6 rb). Perbedaan utamanya: Siloam International Hospitals Tbk. jauh lebih besar — sekitar 254,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SILO | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 26,53 T |
Volume | — | 613,6 rb |
Lot | — | 6,14 rb |
Perputaran | — | 1,24 M |
Harga Rata-rata | — | 2.017,65 |
Nilai Transaksi | — | 1,24 M |
Harga Ekuilibrium Indikatif | — | 2.010 |
Volume Ekuilibrium Indikatif | — | 73 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Siloam International Hospitals Tbk.
PT Siloam International Hospitals Tbk (the Company) was established under its original name of PT Sentralindo Wirasta on August 3, 1996. The Company started commercial operations in 2010 after the restructuring of the hospital unit of PT Lippo Karawaci Tbk.
Selengkapnya di halaman SILO →
